title: Hepatitis B infection in Vanuatu: age of acquisition of infection and possible routes of transmission.
abstract: Seroepidemiological studies of hepatitis B were carried out on diverse groups of children (477) and adults (629) from the Pacific Island country of Vanuatu. In children under 14 years, prevalences of HBsAg and of all markers were 6% and 53.3% respectively; in adults greater than or equal to 20 years the prevalences were 15% and 70%. Age specific prevalence of hepatitis B infection (all markers) was low in infancy (less than 1 year) but rose sharply afterwards, suggesting that the main mechanism of transmission was horizontal spread. This finding is consistent with other developing country studies from the Pacific Islands and elsewhere. In view of the main ages and mechanisms of transmission of hepatitis B in children in developing countries and the need for simple and inexpensive immunisation strategies in this context, it is recommended that mass vaccination of all infants with hepatitis B vaccine be undertaken in hyperendemic areas.
authors.forename: R
authors.initials: R
authors.lastname: Taylor
authors.forename: B
authors.initials: B
authors.lastname: Montaville
authors.forename: S
authors.initials: S
authors.lastname: Levy
authors.forename: I
authors.initials: I
authors.lastname: Gust
authors.forename: J P
authors.initials: JP
authors.lastname: Moreau
authors.forename: M
authors.initials: M
authors.lastname: Dimitrakakis
authors.forename: F
authors.initials: F
authors.lastname: Bach
authors.forename: B
authors.initials: B
authors.lastname: Brethes
authors.forename: M
authors.initials: M
authors.lastname: Laille
authors.forename: D
authors.initials: D
authors.lastname: DeRoeck
mesh_terms: D000293:Adolescent; D000367:Age Factors; D002648:Child; D002675:Child, Preschool; D005260:Female; D006509:Hepatitis B / Q000453:epidemiology* / Q000517:prevention & control / Q000635:transmission; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D015995:Prevalence; D016036:Seroepidemiologic Studies; D009514:Vanuatu / Q000453:epidemiology; D014761:Viral Hepatitis Vaccines / Q000627:therapeutic use
chemical_list: D014761:Viral Hepatitis Vaccines